Difference between revisions of "Team:Oxford"
Noahsprent (Talk | contribs) |
Noahsprent (Talk | contribs) (Undo revision 507475 by Noahsprent (talk)) |
||
| Line 127: | Line 127: | ||
<div class="carousel-caption"> | <div class="carousel-caption"> | ||
<a href="https://2017.igem.org/Team:Oxford/Team"> | <a href="https://2017.igem.org/Team:Oxford/Team"> | ||
| − | <h2 | + | <h2> MEET THE TEAM! </h2> |
</a> | </a> | ||
</div> | </div> | ||
| Line 136: | Line 136: | ||
<div class="carousel-caption"> | <div class="carousel-caption"> | ||
<a href="https://2017.igem.org/Team:Oxford/Team"> | <a href="https://2017.igem.org/Team:Oxford/Team"> | ||
| − | <h2 | + | <h2> MEET THE TEAM! </h2> |
</a> | </a> | ||
</div> | </div> | ||
| Line 145: | Line 145: | ||
<div class="carousel-caption"> | <div class="carousel-caption"> | ||
<a href="https://2017.igem.org/Team:Oxford/Team"> | <a href="https://2017.igem.org/Team:Oxford/Team"> | ||
| − | <h2 | + | <h2> MEET THE TEAM! </h2> |
</a> | </a> | ||
</div> | </div> | ||
| Line 154: | Line 154: | ||
<div class="carousel-caption"> | <div class="carousel-caption"> | ||
<a href="https://2017.igem.org/Team:Oxford/Team"> | <a href="https://2017.igem.org/Team:Oxford/Team"> | ||
| − | <h2 | + | <h2> MEET THE TEAM! </h2> |
</a> | </a> | ||
</div> | </div> | ||
| Line 163: | Line 163: | ||
<div class="carousel-caption"> | <div class="carousel-caption"> | ||
<a href="https://2017.igem.org/Team:Oxford/Team"> | <a href="https://2017.igem.org/Team:Oxford/Team"> | ||
| − | <h2 | + | <h2> MEET THE TEAM! </h2> |
</a> | </a> | ||
</div> | </div> | ||
Revision as of 18:04, 15 December 2017
OXFORD iGEM 2017
See cruzi
Our Project
The aim of our project was to develop a cell-free detection system for congenital Chagas disease in the acute phase by detecting the cruzipain in the blood.
Congenital Chagas disease is a growing global concern and at present, the acute phase of Chagas disease is difficult to diagnose as it is asymptomatic and current diagnostics are both expensive and inaccessible to the majority of those affected. Our final diagnostic kit would allow Chagas disease to be detected by preventing the clotting of a blood sample.
We imagine that this system would be adaptable for other parasites and pathogens which have similar difficulties in detection, both in the input for the system and the options for output.
Sponsors
